Zantac was pulled from store shelves two years ago because its use was linked to various forms of cancer due to the medication containing a product used in the manufacturing of jet fuel.
The Environmental Protection Agency (EPA) has labeled N-nitrosodimethylamine (NDMA) as a probable carcinogen. Furthermore, the Food and Drug Administration (FDA) found the heartburn medication’s use of NDMA could lead to cancer in humans, if taken in a high doses. Sanofi, the manufacturer of the brand-name version of Zantac, recalled its product in 2019. Since then, the company reformulated its recipe, as new versions of the drug sold on shelves today do not contain the cancer-causing chemical.
Brian Kelley, an Associate with Kelley & Ferraro, joined the America’s Work Force Union Podcast to discuss the lawsuits filed against Sanofi by people who used Zantac and developed cancer, as well as other lawsuits by relatives of people who passed away after using Zantac and developing cancer.
He also spoke about the recall of Philips CPAP machines over potential cancer and breathing problems related to a defect in the machines’ foam insulation and potential lawsuits that may result.
Time is running out on Zantac lawsuit
Zantac has been used since the early 1980s and its use of NDMA has been linked to numerous cancers, including:
Kelley explained how some cancer may not appear to be related to the digestive system, but still could be caused by the use of Zantac. He encouraged anyone who used Zantac in the last 30 years and was diagnosed with cancer to call his office at 800-398-1795. He also encouraged relatives of Zantac users who passed away and were diagnosed with cancer to call his office.
Over 125,000 cases have been filed in the Zantac lawsuit nationwide, but Kelley believes the number affected may be substantially higher.
The clock is ticking, as the statute of limitations to file a claim is running out, he said. In Ohio, where Kelley & Ferraro is based, the statute of limitations is two years. Lawyers for plaintiffs will likely argue the statute of limitations should apply to the date of the recall, not the time cancer reports on the drug came out, which was two years ago this month.
Users of Philips Respironics CPAP machines may be entitled to compensation
Last June, Philips Respironics recalled several of its CPAP machines after receiving reports of the insulation foam degrading, causing debris to infiltrate the devices’ airways and into users’ lungs.
Breathing the insulation dust may cause cancer and breathing issues, Kelley said. Since many people using these machines already experience breathing issues, it can be difficult to determine if they are affected.
Symptoms of injury from breathing the dust include:
- Chest pressure
- Sinus infection
- Worsening asthma or increased difficulty with breathing
- Nausea and vomiting
Kelley urged anyone who has used a Philips Respironics CPAP machine to call his office to see if they may be eligible for a claim. He also urged people who have the machines to call the company for a replacement or refund.
Kelley & Ferraro’s help and advice regarding either lawsuit is completely free. The law firm is only paid if they win.